Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy: a Randomized Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04518202

Enrollment

200

Registered

2020-08-19

Start date

2020-09-01

Completion date

2021-09-30

Last updated

2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Brief summary

To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Detailed description

hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, ﬁbroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body. Cervical ripening is made possible by the use of medication through different routes.

Interventions

DRUGlidocaine patch

5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy.

DRUGSham patch

Sham patch containing no study medication applied at 6 hours before the scheduled office hysteroscopy.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

double blinded randomized controlled trial

Intervention model description

double blinded randomized controlled trial

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* patients with an indication for ofﬁce hysteroscopy

Exclusion criteria

* patient refuse to participant * contraindication for lidocaine patch

Design outcomes

Primary

Measure	Time frame	Description
Pain intensity will be assessed by visual analogue scale	10 minutes	Pain intensity will be assessed by visual analogue scale 30 minutes after the procedure. Visual analogue scale ranging from 0 to 10

Secondary

Measure	Time frame	Description
Operative time	15 minutes	From the introduction of hysteroscope into the vagina till compilation of hysteroscopic examination

Countries

Egypt

Contacts

Primary Contacthany f Sallam, md

hany.farouk@aswu.edu.eg+20102435461

Backup Contactnahla w Shady, md

hanygyne@yahoo.com+201022336052

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026